4AT
4AT
The 4AT is a rapid clinical test used in medicine for the detection of delirium and cognitive impairment. It was developed by a team of clinicians and researchers led by Dr. Susan D. Shenkin and Professor Alasdair M.J. MacLullich at the University of Edinburgh in the United Kingdom. The 4AT has been validated in a variety of clinical settings and populations, and is used worldwide.
Overview[edit | edit source]
The 4AT is a brief assessment tool that does not require special training to administer. It consists of four items, hence the name "4AT". The items assess alertness, cognitive impairment, acute change in mental status, and inattention, which are the core features of delirium. The 4AT can be completed in under 2 minutes, making it a practical tool for busy clinical settings.
Components of the 4AT[edit | edit source]
The 4AT consists of the following four items:
- Alertness: This is assessed by observing the patient during the assessment. If the patient is not fully alert, they score 4 points.
- AMT4: This is a brief test of cognitive impairment. The patient is asked to state their age and date of birth, recall the current year, and recall the name of the hospital. Each incorrect answer scores 1 point.
- Acute change or fluctuating course: This is assessed by asking the patient or a relative or carer about any changes in the patient's mental status over the past 2 weeks. If there has been a change, the patient scores 4 points.
- Inattention: This is assessed by asking the patient to say the months of the year backwards. If the patient makes one or more errors, they score 2 points.
A score of 4 or more indicates a high risk of delirium.
Use in Clinical Practice[edit | edit source]
The 4AT is used in a variety of clinical settings, including emergency departments, general medical wards, geriatric wards, and postoperative recovery units. It is also used in research studies investigating delirium and cognitive impairment.
Limitations[edit | edit source]
While the 4AT is a useful tool for detecting delirium and cognitive impairment, it is not a diagnostic tool. A positive 4AT score should prompt further assessment by a healthcare professional with expertise in delirium and cognitive impairment.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
